ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Tenaya Therapeutics Inc

Tenaya Therapeutics Inc (TNYA)

1,41
-1,47
(-51,04%)
Beim Schlusskurs: 17 Dezember 10:00PM
1,42
0,01
( 0,71% )
Nach Börsenschluss: 11:11PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
1,42
Gebot
1,43
Fragen
1,44
Volumen
41.937.012
0,9867 Tagesbereich 2,00
1,39 52-Wochen-Bereich 7,01
Marktkapitalisierung
Handelsende
2,88
Handelsbeginn
2,00
Letzte Trade
97
@
1.43
Letzter Handelszeitpunkt
23:11:49
Finanzvolumen
US$ 61.897.545
VWAP
1,476
Durchschnittliches Volumen (3 Mio.)
3.409.321
Ausgegebene Aktien
79.220.516
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,89
Gewinn pro Aktie (EPS)
-1,57
Erlöse
-
Nettogewinn
-124,08M

Über Tenaya Therapeutics Inc

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and p... Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Tenaya Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TNYA. The last closing price for Tenaya Therapeutics was US$2,88. Over the last year, Tenaya Therapeutics shares have traded in a share price range of US$ 1,39 to US$ 7,01.

Tenaya Therapeutics currently has 79.220.516 shares in issue. The market capitalisation of Tenaya Therapeutics is US$228,16 million. Tenaya Therapeutics has a price to earnings ratio (PE ratio) of -0.89.

TNYA Neueste Nachrichten

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

TN-201 Well Tolerated at 3E13 vg/kg Dose AAV9 Capsid Demonstrated Robust Delivery of TN-201 Transgene to Heart Muscle Cells Resulting in Increasing RNA Expression and an Increase in Protein...

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024

SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

TN-401 AAV9-based Gene Therapy Designed to Deliver Fully Functional PKP2 Gene with the Aim of Increasing Protein Levels to Address Underlying Disease RIDGE-1 Currently Enrolling at Six Centers;...

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-2.52-63.95939086293.944.011.3942841603.04489084CS
4-0.84-37.16814159292.264.011.3948965003.07130133CS
12-0.58-2924.011.3934093212.65785336CS
26-1.98-58.23529411763.44.061.3918159512.67611672CS
52-0.69-32.70142180092.117.011.3911506723.07530805CS
156-18.69-92.938836399820.1122.871.395870063.74826739CS
260-18.08-92.717948717919.5321.395405094.42342701CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PRZOParaZero Technologies Ltd
US$ 2,12
(38,56%)
4,19M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,419
(25,49%)
32,68M
MSPRMSP Recovery Inc
US$ 2,41
(24,23%)
3,71M
LGHLWLion Group Holding Ltd
US$ 0,008
(23,08%)
38,03k
HSCSHeartSciences Inc
US$ 4,6401
(20,52%)
59,11k
AKTSAkoustis Technologies Inc
US$ 0,0153
(-58,87%)
32,76M
OPTOpthea Ltd
US$ 1,81
(-44,56%)
500
FTELFitell Corporation
US$ 27,00
(-29,67%)
340,49k
NIVFNewGenIvf Group Ltd
US$ 0,313
(-26,13%)
1,99M
APDNApplied DNA Sciences Inc
US$ 0,18
(-21,74%)
1,94M
CEROCERo Therapeutics Holdings Inc
US$ 0,0731
(19,64%)
60,16M
AKTSAkoustis Technologies Inc
US$ 0,0153
(-58,87%)
32,76M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,419
(25,49%)
32,68M
RIMEAlgorhythm Holdings Inc
US$ 0,0844
(-4,09%)
7,53M
XTIAXTI Aerospace Inc
US$ 0,0447
(-0,45%)
4,73M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock